PL324026A1 - Application of imidazoles in production of a drug designed to treat leukaemia - Google Patents

Application of imidazoles in production of a drug designed to treat leukaemia

Info

Publication number
PL324026A1
PL324026A1 PL96324026A PL32402696A PL324026A1 PL 324026 A1 PL324026 A1 PL 324026A1 PL 96324026 A PL96324026 A PL 96324026A PL 32402696 A PL32402696 A PL 32402696A PL 324026 A1 PL324026 A1 PL 324026A1
Authority
PL
Poland
Prior art keywords
imidazoles
production
application
drug designed
treat leukaemia
Prior art date
Application number
PL96324026A
Other languages
English (en)
Inventor
James Berger Camden
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of PL324026A1 publication Critical patent/PL324026A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
PL96324026A 1995-06-07 1996-05-22 Application of imidazoles in production of a drug designed to treat leukaemia PL324026A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47381795A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
PL324026A1 true PL324026A1 (en) 1998-05-11

Family

ID=23881113

Family Applications (1)

Application Number Title Priority Date Filing Date
PL96324026A PL324026A1 (en) 1995-06-07 1996-05-22 Application of imidazoles in production of a drug designed to treat leukaemia

Country Status (17)

Country Link
EP (1) EP0831816A1 (xx)
JP (1) JPH11506732A (xx)
KR (1) KR19990022617A (xx)
CN (1) CN1186433A (xx)
AR (1) AR003137A1 (xx)
AU (1) AU717382B2 (xx)
BR (1) BR9608730A (xx)
CA (1) CA2223435A1 (xx)
CZ (1) CZ391197A3 (xx)
HU (1) HUP9802634A3 (xx)
IL (1) IL118424A0 (xx)
NO (1) NO975660L (xx)
PL (1) PL324026A1 (xx)
SK (1) SK168697A3 (xx)
TR (1) TR199701536T1 (xx)
WO (1) WO1996040122A1 (xx)
ZA (1) ZA964373B (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134354C (xx) * 1963-05-23
FR2155888A1 (en) * 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants

Also Published As

Publication number Publication date
BR9608730A (pt) 1999-06-29
NO975660D0 (no) 1997-12-05
CN1186433A (zh) 1998-07-01
HUP9802634A3 (en) 1999-05-28
CA2223435A1 (en) 1996-12-19
TR199701536T1 (xx) 1998-02-21
EP0831816A1 (en) 1998-04-01
KR19990022617A (ko) 1999-03-25
HUP9802634A2 (hu) 1999-03-29
JPH11506732A (ja) 1999-06-15
WO1996040122A1 (en) 1996-12-19
AU717382B2 (en) 2000-03-23
CZ391197A3 (cs) 1998-05-13
IL118424A0 (en) 1996-09-12
AU5802096A (en) 1996-12-30
ZA964373B (en) 1996-09-02
AR003137A1 (es) 1998-07-08
SK168697A3 (en) 1998-12-02
NO975660L (no) 1998-02-09

Similar Documents

Publication Publication Date Title
PL324078A1 (en) Application of bis-1,2,4-triazoles in production of a drug designed to treat carcinomas
PL324026A1 (en) Application of imidazoles in production of a drug designed to treat leukaemia
PL326653A1 (en) Application of epinastin in pain relieving treatments
IL117631A0 (en) Cyclic compounds their production and use
GB9515807D0 (en) Topical hyperbaric bandage
HUP9603112A2 (en) New pharmaceutical formulation and process for its production
GB9506087D0 (en) Improvements relating to medical injection devices
IL118560A0 (en) Ruminant feed and its production
EP0744634A3 (en) Polarizer and its manufacture
PL324107A1 (en) Application of derivatives of 1,2,4-triazole in paroduction of a drug designed to treat carcinomas
PL329790A1 (en) Novel derivatives of imidazolidine, method of obtaining such derivatives, their application in production of a pharmaceutic agent, pharmaceutic agent as such and method of obtaining a pharmaceutic agent
HK1010328A1 (en) Sanitary article capable to improve fit against the body and method and apparatus for manufacturing same
EE9700326A (et) Rakuliin analgeetiliste ühendite tootmiseks valu ravimiseks
AU5884496A (en) Therapeutic sepsis treatment using antagonists to pthrp
GB9523387D0 (en) Production process
GB9624745D0 (en) Ornamental structure of product
ZA96795B (en) An administration form for the release of collagenase to wounds and a process for its production
EE9700166A (et) Melatoniini kasutamine ravimi tootmiseks
GB9526169D0 (en) Manufacture of cellulosic articles
PL326194A1 (en) Method of producing antimalarial medicines
PL331760A1 (en) Application of pkc inhibitors in production of a drug for treating aids
PL327059A1 (en) Derivatives of 5-naphtalen-1-yl 1,3-dioxane, their production and therapeutic application
PL327138A1 (en) Covalent conjugates of lipid-phosphonocarboxylic acids as well as their production and application as antiviral drugs
HUP9900241A3 (en) A method for production of nutrition physiological valuable products and a plant for accomplishing the method
GB9620728D0 (en) A method for the production of footwear and the footwear produced according to this method